Magnesium Sulfate Combined Montelukast Sodium Clinical Observationon Treatment of Infantile Asthma
Xiaoyu M*, Yuntao M and Haitao W
Department of Pediatrics, Zhenan County Maternal and Child Health Care, Zhenan, Shaanxi, China
- *Corresponding Author:
- Xiaoyu M
Department of Pediatrics
Zhenan County Maternal and Child Health Care
Zhenan, Shaanxi, China
Tel: +86 15398082028
E-mail: [email protected]
Received date: April 06, 2016, Accepted date: April 28, 2016, Published date: May 2, 2016
Citation: Xiaoyu M, Yuntao M, Haitao W (2016) Magnesium Sulfate Combined Montelukast Sodium Clinical Observation on Treatment of Infantile Asthma. Neonat Pediatr Med 2: 108. doi: 10.4172/2572-4983.1000108
Copyright: © 2016 Xiaoyu M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Objective: To observe the application of magnesium sulfate combined Montelukast pediatric asthma clinical curative effect of sodium.
Methods: Select zhenan county maternity and child care in November 2014 to November 2015 treated 66 cases of children asthma, randomly divided into control group and research group, 33 cases in each group, control group given conventional treatment, treatment group on the basis of this combined with magnesium sulfate and montelukast sodium, adjuvant therapy, observe the therapeutic effect of two groups.
Results: The treatment group effective rate was 96%, better than the control group 81%, comparing the two groups have significant difference (P < 0.05), and the symptoms disappear time significantly less than the control group.
Conclusion: The application of combined montelukast sodium and magnesium sulfate on infantile asthma with obvious therapeutic effect, less adverse reaction, worth clinical promotion.